Barry Joel Maron MD

PubMed

• Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy.
  Ayman R Fath, Amro Aglan, Martin S Maron, Jason S Phillips, Barry J Maron
  International Journal of Cardiology. 2025-05-01
• Evidence of Declining Mortality Trends for Hypertrophic Cardiomyopathy in the United States and the Impact of the COVID-19 Pandemic.
  Ahmed Sayed, Barry J Maron, Ethan J Rowin, Martin S Maron
  Journal of the American Heart Association. 2025-04-01
• 1 citations
  Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5 Years.
  Daniele Massera, Mark V Sherrid, Elizabeth Adlestein, Nadia Bokhari, Isabel C Alvarez
  Journal of the American Heart Association. 2025-01-21

Journal Articles

• PRKAG2 Glycogen Storage Disease Cardiomyopathy Out of the Darkness and into the Light  
  Barry Maron, MD, JACC: Cardiovascular Imaging
• Original Investigation Editorial Comment Survival After Takotsubo, Revisited∗  
  Scott W Sharkey, Barry J Maron, ScienceDirect
• Mini-Focus Issue: Hypertrophic Cardiomyopathy State-of-the-Art Review Clinical Spectrum and Management of Heart Failure in Hypertrophic Cardiomyopathy  
  Martin S Maron, Barry J Maron, James E Udelson, Ethan J Rowin, ScienceDirect

Lectures

• My Patient is Diagnosed With HCM: Best Practices for My Patient and Their Family 
  2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019